Dony Philippe, Dramaix Michele, Boogaerts Jean G
Department of Anesthesiology, University Hospital Center of Charleroi, Belgium.
School of Public Health, Research Center for Epidemiology, Free University of Brussels, 1070 Brussels, Belgium.
J Clin Anesth. 2017 Feb;36:123-126. doi: 10.1016/j.jclinane.2016.10.028. Epub 2016 Dec 2.
To evaluate the relationship between intraoperative end-tidal carbon dioxide (etco) values and clinical outcomes with special attention on 30-day postoperative mortality and secondarily on hospital length of stay (LOS).
Retrospective, observational study.
Surgical theaters of the University Hospital Center of Charleroi.
Five thousand three hundred seventeen patients ASA I-IV undergoing various surgical procedures (except pediatric and cardiac surgery) under general anesthesia.
No intervention on the patients.
The mean etco level measured during anesthesia was secondarily extracted from an electronic information management system. Patients were divided into 2 separate groups based on etco values less than or greater than or equal to 35 mm Hg. The primary end point was the in- and outhospital mortality in the 30-day period after surgery. The second was the LOS more than 6 days.
Hypocapnia occurred in 66% of the patients. Mortality rate at 30-day was 84 of 3554 (2.4%) in the low etco group vs 15 of 1763 (0.9%) in the other (odds ratio, 2.99 [1.69-5.28]; P<.001). In multivariate analysis, age and ASA scores had significant independent associations with mortality rate. Adjusting for these factors had an effect on the relative odds ratio of etco on mortality of 1.99 ([1.11-3.56]; P<.001). Patients with low etco experienced higher LOS (14.1±9.4 vs 13.1±8.9 days; P<.001). Thirty five percent of the patients in the low etco group were still hospitalized more than 6 days compared with 30% in the other (P<.001).
Low etco level during anesthesia is associated with an increase in postoperative mortality rate and LOS. These results emphasize the importance of preventing hypocapnia during anesthesia to improve surgical outcomes.
评估术中呼气末二氧化碳(EtCO)值与临床结局之间的关系,特别关注术后30天死亡率,其次关注住院时间(LOS)。
回顾性观察研究。
沙勒罗瓦大学医院中心手术室。
5317例美国麻醉医师协会(ASA)分级为I-IV级、接受全身麻醉下各种外科手术(儿科和心脏手术除外)的患者。
未对患者进行干预。
麻醉期间测得的平均EtCO水平其次从电子信息管理系统中提取。根据EtCO值小于或大于或等于35 mmHg将患者分为2个独立组。主要终点是术后30天内的院内和院外死亡率。第二个终点是住院时间超过6天。
66%的患者发生低碳酸血症。低EtCO组3554例患者中30天死亡率为84例(2.4%),而另一组1763例患者中为15例(0.9%)(优势比,2.99 [1.69 - 5.28];P <.001)。多因素分析中,年龄和ASA评分与死亡率有显著独立关联。校正这些因素后,EtCO对死亡率的相对优势比为1.99([1.11 - 3.56];P <.001)。EtCO低的患者住院时间更长(14.1±9.4天 vs 13.1±8.9天;P <.001)。低EtCO组35%的患者住院时间仍超过6天,而另一组为30%(P <.001)。
麻醉期间EtCO水平低与术后死亡率增加和住院时间延长有关。这些结果强调了麻醉期间预防低碳酸血症以改善手术结局的重要性。